Email Updates

You are here

Trial Summary Table

Trial Name Phase Start Date Sponsors Countries Population Candidate(s) Status Expected Completion Date
Sustainable Healthcenter Implementation PrEP Pilot Study (SHIPP) Other Wednesday, October 1, 2014 CDC, CDC Foundation United States of America Women, Men, Injecting drug users, MSM Ongoing May 2017
TAPS Demonstration Project Demo Project Wednesday, April 1, 2015 BMGF South Africa Women Ongoing April 2017
TDF2 III, II Saturday, March 31, 2007 Botswana Ministry of Health, US Centers for Disease Control Botswana Men, Women TDF/FTC (Truvada) Completed March 2011
The Demo Project Demo Project Wednesday, October 1, 2014 National Institute of Allergy and Infectious Diseases of the NIH United States of America MSM TDF/FTC (Truvada) Completed January 2015
The Queensland Pre-Exposure Prophylaxis Demonstration Project Expansion (QPrEPd) Demo Project Friday, July 29, 2016 Queensland Health/Queensland AIDS Council/University of Queensland Australia Planned
TMC278-MWRI-01 I Friday, November 2, 2012 Janssen Research & Development, LLC United States of America Women, Men TMC 278 Completed January 2016
Trans Research-Informed Communities United in Mobilization for the Prevention of HIV (TRIUMPH) Demo Project The California HIV/AIDS Research Program (CHRP) of the University of California United States of America Planned
Transdermal Delivery System for Tenofovir Alafenamide Pre-clinical Eastern Virginia Medical School, CONRAD, Corporation of Mercer University, USAID/PEPFAR F/TAF Stopped Early
Transgender-Focused PrEP Demo Project - Case Management Approach Demo Project California HIV/AIDS Research Program (CHRP) of the University of California United States of America Planned
Transgender-Focused PrEP Demo Project - Medical Homes Approach Demo Project California HIV/AIDS Research Program (CHRP) of the University of California United States of America Planned

Pages